Philippe J. Amouyal

Insider Reports History

Location
Washington, DC
Signature
/s/ Philippe J. Amouyal
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Philippe J. Amouyal:

Company Role Class Num Shares Value Price $ Report Date Ownership
CAVA GROUP, INC. Director Common Stock 18,074 $1,480,441 $81.91 20 Jun 2025 Direct
LEXICON PHARMACEUTICALS, INC. Director Common Stock 285,174 $145,438 $0.5100 13 May 2025 Direct
LEXICON PHARMACEUTICALS, INC. Director Restricted Stock Units 35,714 $96,442 $2.62 01 May 2026 Direct
LEXICON PHARMACEUTICALS, INC. Director Stock Option (Right to Buy) 43,478 01 May 2026 Direct

Insider Reports Filed by Philippe J. Amouyal

Symbol Company Period Transactions Value $ Form Type Role Filing Time
LXRX LEXICON PHARMACEUTICALS, INC. 01 May 2026 2 $0 4 Director 04 May 2026, 16:59
CAVA CAVA GROUP, INC. 20 Jun 2025 1 $0 4 Director 24 Jun 2025, 17:23
LXRX LEXICON PHARMACEUTICALS, INC. 03 Jun 2025 2 $0 4 Director 03 Jun 2025, 16:21
LXRX LEXICON PHARMACEUTICALS, INC. 13 May 2025 2 $0 4 Director 13 May 2025, 17:49
CAVA CAVA GROUP, INC. 20 Jun 2024 1 $0 4 Director 24 Jun 2024, 16:05
LXRX LEXICON PHARMACEUTICALS, INC. 13 May 2024 2 $0 4 Director 13 May 2024, 16:00
LXRX LEXICON PHARMACEUTICALS, INC. 28 Apr 2024 2 $0 4 Director 29 Apr 2024, 16:16
CAVA CAVA GROUP, INC. 17 Nov 2023 1 +$331,800 4 Director 21 Nov 2023, 16:00
LXRX LEXICON PHARMACEUTICALS, INC. 13 Nov 2023 1 +$201,520 4 Director 14 Nov 2023, 16:12
CAVA CAVA GROUP, INC. 20 Jun 2023 1 $0 4 Director 22 Jun 2023, 16:36
CAVA CAVA GROUP, INC. 15 Jun 2023 0 $0 3 Director 15 Jun 2023, 16:37
LXRX LEXICON PHARMACEUTICALS, INC. 21 May 2023 2 $0 4 Director 22 May 2023, 16:01
LXRX LEXICON PHARMACEUTICALS, INC. 28 Apr 2023 2 $0 4 Director 28 Apr 2023, 16:21
LXRX LEXICON PHARMACEUTICALS, INC. 21 May 2022 2 $0 4 Director 23 May 2022, 16:12
LXRX LEXICON PHARMACEUTICALS, INC. 30 Apr 2022 2 $0 4 Director 02 May 2022, 16:11
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .